Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.7.1.227 extracted from

  • Mandlik, V.; Singh, S.
    Molecular docking and molecular dynamics simulation study of inositol phosphorylceramide synthase - inhibitor complex in leishmaniasis Insight into the structure based drug design (2016), F1000Res., 5, 1610 .
    View publication on PubMed

Inhibitors

Inhibitors Comment Organism Structure
3-(1,3-benzodioxol-5-yl)-6-[[(1E)-1H-pyrrol-2-ylmethylene]amino]-2H-chromene-2-one coumarin derivative. Molecular dynamics modeling, free energy of binding is -9.5 kcal/mol Leishmania major
3-(2H-1,3-benzodioxol-5-yl)-6-[(E)-[(furan-2-yl)methylidene]amino]-2H-1-benzopyran-2-one coumarin derivative with little cytotoxic effects.Molecular dynamics modeling, free energy of binding is -9.8 kcal/mol Leishmania major

Organism

Organism UniProt Comment Textmining
Leishmania major
-
-
-